Xinhua News Agency, Beijing, September 12 (Reporter Lin Miaomiao) A team led by Professor Cai Jun of the Hypertension Center of Fuwai Hospital of the Chinese Academy of Medical Sciences found that controlling the systolic blood pressure within 130 mmHg in elderly hypertensive patients in China can be effective Provides clinical benefit and is relatively safe, this result is lower than the currently generally accepted target value
Academy of Sciences With the progress of population aging, the target of blood pressure reduction in elderly hypertensive patients has become a hot issue that has attracted much attention from scholars at home and abroad
More than 8,000 elderly hypertensive patients screened in the study were randomly divided into the intensive blood pressure group (the systolic blood pressure target is 110 mmHg to 130 mmHg) and the standard blood pressure group (the systolic blood pressure target is 130 mmHg) To 150 mmHg)
The study found that compared with the standard antihypertensive group, intensive antihypertensive group can reduce the risk of major cardiovascular composite outcomes by 26%, reduce the risk of acute coronary syndrome by 33%, reduce the risk of stroke by 33%, and reduce the risk of acute decompensated heart failure Reduced by 73%
This result was published in the international authoritative medical journal "New England Journal of Medicine".
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
